Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

ClinicalTrials.gov ID: NCT02694978

Public ClinicalTrials.gov record NCT02694978. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 7:29 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Randomized, Multicenter, Double-Blind, Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the safety of 1.020 grams (g) of intravenous (IV) ferumoxytol compared to 1.500 g of IV ferric carboxymaltose (FCM).

Study identification

NCT ID
NCT02694978
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AMAG Pharmaceuticals, Inc.
Industry
Enrollment
2,014 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2016 (Actual)
Primary completion
Jan 16, 2017 (Actual)
Completion
Jul 17, 2017 (Actual)
Last update posted
Jul 25, 2023

2016 – 2017

United States locations

U.S. sites
100
U.S. states
27
U.S. cities
86
Facility City State ZIP Site status
Clinical Trial Site Huntsville Alabama — —
Clinical Trial Site Tucson Arizona 85741 —
Clinical Trial Site Tucson Arizona — —
Clinical Trial Site Anaheim California — —
Clinical Trial Site Chula Vista California — —
Clinical Trial Site Corona California — —
Clinical Trial Site Encino California — —
Clinical Trial Site Fountain Valley California — —
Clinical Trial Site Granada Hills California — —
Clinical Trial Site La Mesa California — —
Clinical Trial Site Orange California — —
Clinical Trial Site Oxnard California — —
Clinical Trial Site Riverside California — —
Clinical Trial Site San Diego California — —
Clinical Trial Site West Hollywood California — —
Clinical Trial Site Westminster California — —
Clinical Trial Site Bristol Connecticut — —
Clinical Trial Site Norwalk Connecticut — —
Clinical Trial Site Clearwater Florida — —
Clinical Trial Site Gainesville Florida — —
Clinical Trial Site Lauderdale Lakes Florida 33313 —
Clinical Trial Site Lauderdale Lakes Florida — —
Clinical Trial Site Miami Florida 33135 —
Clinical Trial Site Miami Florida — —
Clinical Trial Site Miami Lakes Florida — —
Clinical Trial Site North Miami Florida — —
Clinical Trial Site South Miami Florida — —
Clinical Trial Site West Palm Beach Florida — —
Clinical Trial Site Winter Haven Florida — —
Clinical Trial Site Atlanta Georgia — —
Clinical Trial Site Augusta Georgia — —
Clinical Trial Site Savannah Georgia — —
Clinical Trial Site Thomasville Georgia — —
Clinical Trial Site Elk Grove Village Illinois — —
Clinical Trial Site Evergreen Park Illinois — —
Clinical Trial Site Hazel Crest Illinois — —
Clinical Trial Site Skokie Illinois 60202 —
Clinical Trial Site Skokie Illinois — —
Clinical Trial Site Wichita Kansas — —
Clinical Trial Site Crestview Hills Kentucky — —
Clinical Trial Site Metairie Louisiana — —
Clinical Trial Site New Orleans Louisiana — —
Clinical Trial Site Baltimore Maryland — —
Clinical Trial Site Bethesda Maryland — —
AMAG Pharmaceuticals, Inc. Waltham Massachusetts 02451 —
Clinical Trial Site Bay City Michigan — —
Clinical Trial Site Flint Michigan — —
Clinical Trial Site Saginaw Michigan 48706 —
Clinical Trial Site Saginaw Michigan — —
Clinical Trial Site Chesterfield Missouri — —
Clinical Trial Site Kansas City Missouri — —
Clinical Trial Site Kirksville Missouri — —
Clinical Trial Site Las Vegas Nevada — —
Clinical Trial Site East Setauket New York — —
Clinical Trial Site Flushing New York — —
Clinical Trial Site New York New York — —
Clinical Trial Site Rosedale New York — —
Clinical Trial Site Asheville North Carolina 28801 —
Clinical Trial Site Asheville North Carolina — —
Clinical Trial Site Charlotte North Carolina — —
Clinical Trial Site Greensboro North Carolina — —
Clinical Trial Site Hickory North Carolina — —
Clinical Trial Site Jacksonville North Carolina — —
Clinical Trial Site Morehead City North Carolina — —
Clinical Trial Site Raleigh North Carolina — —
Clinical Trial Site Wilmington North Carolina — —
Clinical Trial Site Winston-Salem North Carolina — —
Clinical Trial Site Cincinnati Ohio 45224 —
Clinical Trial Site Cincinnati Ohio — —
Clinical Trial Site Marion Ohio — —
Clinical Trial Site Norman Oklahoma — —
Clinical Trial Site Tulsa Oklahoma 74104 —
Clinical Trial Site Tulsa Oklahoma — —
Clinical Trial Site Jenkintown Pennsylvania — —
Clinical Trial Site Levittown Pennsylvania — —
Clinical Trial Site Scottdale Pennsylvania — —
Clinical Trial Site Smithfield Pennsylvania — —
Clinical Trial Site Upland Pennsylvania — —
Clinical Trial Site Greenville South Carolina 29615 —
Clinical Trial Site Greenville South Carolina — —
Clinical Trial Site Greer South Carolina — —
Clinical Trial Site Rapid City South Dakota — —
Clinical Trial Site Germantown Tennessee — —
Clinical Trial Site Kingsport Tennessee — —
Clinical Trial Site Memphis Tennessee — —
Clinical Trial Site Austin Texas — —
Clinical Trial Site Fort Sam Houston Texas — —
Clinical Trial Site Houston Texas 77030 —
Clinical Trial Site Houston Texas 77081 —
Clinical Trial Site Houston Texas — —
Clinical Trial Site Longview Texas — —
Clinical Trial Site San Antonio Texas 78215 —
Clinical Trial Site San Antonio Texas 78217 —
Clinical Trial Site San Antonio Texas 78229 —
Clinical Trial Site San Antonio Texas — —
Clinical Trial Site Schertz Texas — —
Clinical Trial Site Orem Utah — —
Clinical Trial Site Fredericksburg Virginia — —
Clinical Trial Site Norfolk Virginia — —
Clinical Trial Site Seattle Washington — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02694978, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 25, 2023 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02694978 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →